Beta Bionics, Inc. (BBNX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Beta Bionics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -16.87x | -2.75x | -2.84x | -1.82x |
| P/B Ratio | 4.29x | 1.98x | 2.14x | 9.08x |
| P/S Ratio | 12.32x | 2.31x | 10.45x | 659.73x |
| Profitability | ||||
| Gross Margin | 55.4% | 55.1% | 52.6% | 100.0% |
| Operating Margin | -71.5% | -69.5% | -298.9% | -36784.4% |
| Net Margin | -73.0% | -84.1% | -367.6% | -36173.7% |
| EBITDA Margin | -73.0% | -67.7% | -288.7% | -35418.4% |
| Liquidity | ||||
| Current Ratio | 8.66x | 6.29x | 9.77x | 3.21x |
| Quick Ratio | 7.96x | 5.66x | 9.65x | 3.21x |
| Leverage | ||||
| Debt/Equity | 0.03x | 0.10x | 0.07x | 0.32x |
YoY = year-over-year change. Source: FMP..